Search research articles
Contact Us
Filters
Showing results (141-150 of 177) with videos related to
Page
of 18
Sort By:
The European Respiratory Journal
|
March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adults
Saskia Bos, John Murray, Monia Marchetti, et al.
The Lancet. Haematology
|
January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Blood
|
May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
Katharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Frontiers in Immunology
|
September 26, 2018
Increased Risk for Malignancies in 131 Affected <i>CTLA4</i> Mutation Carriers
David Egg, Charlotte Schwab, Annemarie Gabrysch, et al.
Blood Advances
|
November 9, 2022
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
Daniela Weber, Markus Weber, Elisabeth Meedt, et al.
The New England Journal of Medicine
|
September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Daniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Blood
|
February 2, 2021
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease
Yun Zhang, Lichong Shen, Katja Dreißigacker, et al.
The Lancet. Haematology
|
March 5, 2025
Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
Hélène Schoemans, Elke Stienissen, Kathy Goris, et al.
Annals of Hematology
|
November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Transplantation and Cellular Therapy
|
May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Alexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 177) with videos related to
Sort By:
Page
of 18
The European Respiratory Journal
|
March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adults
Saskia Bos, John Murray, Monia Marchetti, et al.
The Lancet. Haematology
|
January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Blood
|
May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
Katharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Frontiers in Immunology
|
September 26, 2018
Increased Risk for Malignancies in 131 Affected <i>CTLA4</i> Mutation Carriers
David Egg, Charlotte Schwab, Annemarie Gabrysch, et al.
Blood Advances
|
November 9, 2022
Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
Daniela Weber, Markus Weber, Elisabeth Meedt, et al.
The New England Journal of Medicine
|
September 18, 2024
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
Daniel Wolff, Corey Cutler, Stephanie J Lee, et al.
Blood
|
February 2, 2021
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease
Yun Zhang, Lichong Shen, Katja Dreißigacker, et al.
The Lancet. Haematology
|
March 5, 2025
Ask, do not tell: consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
Hélène Schoemans, Elke Stienissen, Kathy Goris, et al.
Annals of Hematology
|
November 16, 2020
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, et al.
Transplantation and Cellular Therapy
|
May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Alexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Page
of 18